EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Association of Sex and Smoking Status With Cross-Spread Graft Outcomes in Septorhinoplasty: A Retrospective Study

Sinem Gökçe Kütük, Ömer Erdağ

The European Research Journal · 2026-09-08 · 1-9

DOI: 10.18621/eurj.1402 ↗
AbstractBibliografische Angaben

Abstract

Objective: The cross-spreader graft technique (CSGT) in septorhinoplasty is a relatively novel procedure, and evidence regarding patient-related factors influencing its outcomes remains limited. This study aimed to evaluate whether biological sex and smoking status are associated with clinical and functional outcomes following CSGT. Methods: This retrospective study evaluated 50 patients who underwent septorhinoplasty using the CSGT between 2022 and 2024. Patient demographics and smoking status were recorded. Functional and aesthetic outcomes were measured using the Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS). Statistical analyses were performed to compare outcomes based on sex distribution and smoking status. Results: A total of 50 patients (31 females [62%] and 19 males [38%]; 21 smokers [42%] and 29 nonsmokers [58%]) were evaluated. Postoperative SCHNOS scores demonstrated statistically significant improvements across all domains, including nasal function, cosmetic appearance, and total scores, for the entire cohort (P < .001). No statistically significant differences in postoperative SCHNOS scores were observed between male and female patients, or between smokers and nonsmokers (all P > .05). Conclusions: The CSGT is an effective technique in septorhinoplasty for both functional and aesthetic improvement. These outcomes appear to be independent of patient sex and smoking status.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →